Corteva, Inc.

10-K & 10-Q Filings

Corteva, Inc. is a leading global provider of seed and crop protection solutions in the agriculture industry. It was incorporated in Delaware in 2018 and is headquartered in Indianapolis, Indiana. Corteva became an independent, publicly traded company on June 1, 2019, following the separation of the agriculture business from DowDuPont Inc. The company's business strategy focuses on developing and supplying commercial seed with advanced germplasm and traits, and crop protection products that protect against weeds, insects, and disease. Corteva's operations are managed through two reportable segments: seed and crop protection. The seed segment is a global leader in developing and supplying commercial seed, including corn and soybean seeds, and offers trait technologies that improve resistance to weather, disease, insects, and enhance food and nutritional characteristics. The crop protection segment serves the global agricultural input industry with products that protect against weeds, insects, and other pests, and disease, and improve overall crop health. Corteva's website is www.corteva.com, and its common stock is traded on the New York Stock Exchange under the ticker symbol "CTVA". The company's major brands and technologies in the seed segment include Pioneer® seeds, ENLIST™ corn, ENLIST E3™ soybeans, and Lumisena™, while in the crop protection segment, major brands and technologies include CLOSER™, INTREPID®, and VYDATE®. Corteva's business segments, seed and crop protection, generate approximately 65% and 35% of sales, respectively. The company's sales are strongest in the first half of the calendar year due to the planting and growing season in the northern hemisphere. Corteva aims to attract and retain the best employees, promote a culture of safety, and foster inclusion and diversity in the workplace. The company's intellectual property estate includes patents, trade secrets, trademarks, and copyrights, which it actively seeks to secure and protect. Competition in the industry is intense, and Corteva competes based on germplasm and trait leadership, price, quality, and cost competitiveness. The company's key competitors include BASF, Bayer, FMC, Syngenta, and ChemChina.

12 mos ending Dec 31, 201112 mos ending Dec 31, 201212 mos ending Dec 31, 201312 mos ending Dec 31, 201412 mos ending Dec 31, 201512 mos ending Dec 31, 201612 mos ending Dec 31, 201812 mos ending Dec 31, 201912 mos ending Dec 31, 202012 mos ending Dec 31, 202112 mos ending Dec 31, 202212 mos ending Dec 31, 20233 mos ending Mar 31, 20233 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$37961.00
34812.00
35734.00
34723.00
25130.00
24594.00
26279.00
13846.00
14217.00
15655.00
17455.00
17226.00
4884.00
4492.00
-6.93%-8.03%Cost of Revenue (-)
$
22548.00
21703.00
15112.00
14469.00
18182.00
8575.00
8507.00
9220.00
10436.00
9920.00
2771.00
2550.00
-7.98%Gross Profit (+)
$
13186.00
13020.00
10018.00
10125.00
8097.00
5271.00
5710.00
6435.00
7019.00
7306.00
2113.00
1942.00
-8.09%Selling, General & Administrative (-)
$4170.00
3567.00
3554.00
5344.00
4615.00
4319.00
3853.00
3065.00
3043.00
3209.00
3173.00
3176.00
726.00
736.00
-2.45%1.38%Research & Development (-)
$1956.00
2067.00
2153.00
2067.00
1898.00
1641.00
1524.00
1147.00
1142.00
1187.00
1216.00
1337.00
316.00
332.00
-3.40%5.06%Depreciation & Amortization (-)
$
1281.00
475.00
682.00
722.00
702.00
683.00
160.00
177.00
10.63%Non-recurring Operating Expenses (-)
$50.00
6363.00
966.00
336.00
75.00
18.91%Operating Expenses (-)
$6176.00
5634.00
10107.00
9352.00
6972.00
6646.00
13021.00
5653.00
4867.00
5118.00
5091.00
5532.00
1202.00
1320.00
-1.00%9.82%Costs & Expenses (Total) (-)
$34437.00
32195.00
32655.00
31055.00
22084.00
21115.00
31203.00
14228.00
13374.00
14338.00
15527.00
15452.00
3973.00
3870.00
-7.03%-2.59%Operating Income/Loss (+)
$3524.00
2617.00
3079.00
3668.00
3046.00
3479.00
-4924.00
-382.00
843.00
1317.00
1928.00
1774.00
911.00
622.00
-6.05%-31.72%Non-operating Income/Expense (+)
$
462.00
202.00
212.00
1348.00
-60.00
-448.00
-71.00
-99.00
-39.44%Interest Expense (-)
$447.00
464.00
448.00
377.00
342.00
370.00
Earnings before Tax (+)
$4282.00
3115.00
3489.00
4991.00
2591.00
3265.00
-4793.00
-316.00
675.00
2346.00
1426.00
1093.00
776.00
482.00
-11.67%-37.89%Tax Expense (-)
$772.00
622.00
626.00
1370.00
696.00
744.00
220.00
-46.00
-81.00
524.00
210.00
152.00
169.00
106.00
-13.73%-37.28%Income/Loss (Continuing Operations) (+)
$3510.00
2493.00
2863.00
3621.00
1895.00
2521.00
-5013.00
-270.00
756.00
1822.00
1216.00
941.00
607.00
376.00
-11.28%-38.06%Income/Loss (Discontinued Operations) (+)
$
320.00
1999.00
15.00
4.00
-5.00
-671.00
-55.00
-53.00
-58.00
-194.00
-8.00
47.00
687.50%Profit/Loss (+)
$3510.00
2813.00
4862.00
3636.00
1959.00
2525.00
-5018.00
-941.00
701.00
1769.00
1158.00
747.00
599.00
423.00
-13.12%-29.38%Net Income/Loss (NCI) (-)
$36.00
25.00
14.00
11.00
6.00
12.00
11.00
18.00
20.00
10.00
12.00
4.00
4.00
-9.50%0.00%Net Income/Loss (+)
$3474.00
2788.00
4848.00
3625.00
1953.00
2513.00
-5029.00
-959.00
681.00
1759.00
1147.00
735.00
595.00
419.00
-13.17%-29.58%Net Income/Loss (Common) (+)
$3474.00
2788.00
4848.00
3625.00
1953.00
2513.00
-5029.00
-959.00
681.00
1759.00
1147.00
735.00
595.00
419.00
-13.17%-29.58%EPS (Basic)
$3.73
2.98
5.22
3.95
2.17
2.87
-1.28
0.91
2.39
1.59
1.04
0.84
0.60
-10.96%-28.57%EPS (Diluted)
$3.68
2.95
5.18
3.92
2.16
2.85
-1.28
0.91
2.37
1.58
1.03
0.83
0.60
-10.93%-27.71%Weighted Avg Shares (Basic)
932.25
934.29
927.72
905.41
871.68
864.57
0.00
0.00
744.06
727.02
712.82
701.78
710.87
696.98
-2.55%-1.95%Cash
$3586.00
4284.00
8941.00
6910.00
5300.00
4605.00
4466.00
1764.00
3526.00
4459.00
3191.00
2644.00
1646.00
1505.00
-2.73%-8.57%Short-term Investments
$433.00
123.00
145.00
124.00
906.00
1362.00
34.00
5.00
269.00
86.00
124.00
98.00
85.00
153.00
-12.63%80.00%Receivables
$6022.00
5452.00
6047.00
6005.00
4643.00
4971.00
5534.00
5528.00
4926.00
4811.00
5701.00
5488.00
8678.00
7906.00
-0.84%-8.90%Inventory
$7195.00
7422.00
8042.00
7841.00
6140.00
5673.00
7407.00
5032.00
4882.00
5180.00
6811.00
6899.00
6585.00
6183.00
-0.38%-6.10%Prepaid Expenses (Current)
$151.00
204.00
206.00
279.00
248.00
506.00
Other Assets (Current)
$671.00
3706.00
1003.00
589.00
518.00
1165.00
1190.00
1165.00
1010.00
968.00
1131.00
1335.00
1416.00
4.86%6.07%Assets (Current)
$18058.00
21191.00
24384.00
21748.00
17755.00
17117.00
18606.00
13519.00
14768.00
15546.00
16795.00
16260.00
18329.00
17163.00
-0.95%-6.36%Securities & Long-term Investments
$1117.00
1163.00
1011.00
886.00
688.00
649.00
1381.00
66.00
66.00
76.00
102.00
115.00
87.00
123.00
-18.67%41.38%Property, Plant & Equipment (Net)
$13412.00
12741.00
12993.00
13386.00
9784.00
9231.00
12186.00
4546.00
4396.00
4329.00
4254.00
4287.00
8542.00
4206.00
-9.85%-50.76%Accumulated Depreciation
$19349.00
19085.00
19438.00
19942.00
14346.00
14736.00
1720.00
3326.00
3857.00
4035.00
4297.00
4669.00
4362.00
4807.00
-12.12%10.20%Goodwill & Intangibles
$5413.00
9742.00
9809.00
9109.00
8392.00
7844.00
66739.00
21653.00
21016.00
10107.00
19301.00
20231.00
20645.00
19999.00
12.73%-3.13%Other Assets
$5079.00
7955.00
3530.00
4747.00
4547.00
5123.00
393.00
2613.00
2403.00
8251.00
2166.00
2103.00
2168.00
2134.00
-7.70%-1.57%Assets (Non-current)
$30434.00
28545.00
27343.00
28128.00
23411.00
22847.00
82419.00
28878.00
27881.00
26798.00
25823.00
26736.00
27171.00
26462.00
-1.17%-2.61%Assets (Total)
$48492.00
49736.00
51499.00
49876.00
41166.00
39964.00
101025.00
42397.00
42649.00
42344.00
42618.00
42996.00
45500.00
43625.00
-1.09%-4.12%Accounts Payable
$10113.00
10850.00
11399.00
10670.00
8978.00
8468.00
9281.00
8231.00
8545.00
6340.00
7332.00
6805.00
6732.00
6490.00
-3.54%-3.59%Debt (Current)
$817.00
1275.00
1721.00
1423.00
1165.00
429.00
2160.00
7.00
3.00
17.00
24.00
198.00
3787.00
2148.00
-12.09%-43.28%Other Liabilities (Current)
$255.00
1424.00
247.00
547.00
210.00
3201.00
3388.00
3406.00
2712.00
2694.00
26.57%-0.66%Liabilities (Current)
$11185.00
13549.00
13367.00
12640.00
10353.00
8897.00
11441.00
8238.00
8548.00
9558.00
10744.00
10409.00
13231.00
11332.00
-0.65%-14.35%Debt (Non-current)
$11736.00
10465.00
10741.00
9271.00
7642.00
8107.00
5812.00
115.00
1102.00
1100.00
1283.00
2291.00
1670.00
2492.00
-13.80%49.22%Other Liabilities
$16509.00
15543.00
11105.00
14587.00
12971.00
12764.00
13684.00
9489.00
7936.00
6063.00
5050.00
5017.00
5189.00
4793.00
-10.26%-7.63%Liabilities (Non-current)
$28245.00
26008.00
21846.00
23858.00
20613.00
20871.00
19496.00
9604.00
9038.00
7163.00
6333.00
7308.00
6859.00
7285.00
-11.57%6.21%Liabilities (Total)
$39430.00
39557.00
35213.00
36498.00
30966.00
29768.00
30937.00
17842.00
17586.00
16721.00
17077.00
17717.00
20090.00
18617.00
-7.01%-7.33%Treasury Stock
$6727.00
6727.00
6727.00
6727.00
6727.00
6727.00
Retained Earnings
$13422.00
14286.00
16784.00
17045.00
14510.00
14924.00
-7669.00
-425.00
524.00
250.00
3706.00
487.00
302.00
-11.04%-37.99%AOCI
$-8750.00
-8646.00
-5441.00
-8707.00
-9396.00
-9911.00
-2503.00
-3270.00
-2890.00
-2898.00
-2806.00
-2677.00
-2739.00
-3010.00
-9.89%Shareholder's Equity
$9062.00
10179.00
16286.00
13378.00
10200.00
10196.00
70088.00
24555.00
25063.00
25623.00
25541.00
25279.00
25839.00
25008.00
9.77%-3.22%Liabilities & Equity
$48492.00
49736.00
51499.00
49876.00
41166.00
39964.00
101025.00
42397.00
42649.00
42344.00
42618.00
42996.00
45500.00
43625.00
-1.09%-4.12%Net Income/Loss
$3510.00
2813.00
4862.00
3636.00
1959.00
2525.00
-5018.00
-941.00
701.00
1769.00
1158.00
747.00
599.00
423.00
-13.12%-29.38%Depreciation & Amortization
$1560.00
1713.00
1603.00
1617.00
1466.00
1258.00
2589.00
1599.00
2354.00
2486.00
1223.00
1211.00
287.00
307.00
-2.28%6.97%Increase/Decrease in Working Capital
$569.00
15.00
1145.00
1272.00
1586.00
1132.00
-631.00
556.00
-359.00
-656.00
1549.00
786.00
-994.00
3336.00
2.98%435.61%Share-based Compensation
$-341.00
-848.00
-313.00
-311.00
-308.00
-535.00
-322.00
-264.00
-409.00
138.00
36.00
41.00
13.89%Adjustments to Reconcile Net Income
$1642.00
2036.00
-1683.00
76.00
357.00
775.00
5866.00
2011.00
1363.00
958.00
-286.00
1022.00
-3910.00
-3032.00
-4.22%22.46%Net Cash (Operating)
$5152.00
4849.00
3179.00
3712.00
2316.00
3300.00
848.00
1070.00
2064.00
2727.00
872.00
1769.00
-3311.00
-2609.00
-9.26%21.20%Capital Expenditure
$8369.00
1908.00
-2768.00
1004.00
1718.00
1038.00
1319.00
913.00
393.00
502.00
617.00
2083.00
-1312.00
148.00
-11.88%111.28%Net Cash (Investing)
$-6238.00
-1346.00
2945.00
-337.00
-1828.00
-1514.00
-334.00
-904.00
-674.00
-362.00
-632.00
-1987.00
-1511.00
-270.00
82.13%Increase/Decrease in Debt
$1561.00
-793.00
717.00
-1701.00
2141.00
-240.00
-4797.00
-3650.00
436.00
-1286.00
-1169.00
325.00
3293.00
2141.00
-13.30%-34.98%Increase/Decrease in Equity
$-672.00
-400.00
-1000.00
-2000.00
-2353.00
-916.00
85.00
22.00
-219.00
-850.00
-912.00
-725.00
-245.00
-244.00
0.41%Interest Expenses
$455.00
501.00
489.00
394.00
341.00
386.00
918.00
263.00
36.00
30.00
75.00
234.00
-5.87%Dividends Paid
$1533.00
1594.00
1661.00
1696.00
1546.00
1335.00
10.00
-194.00
-388.00
-397.00
-418.00
439.00
107.00
112.00
-10.75%4.67%Net Cash (Financing)
$403.00
-2697.00
-1474.00
-5074.00
-1823.00
-2328.00
-3112.00
-2929.00
303.00
-1266.00
-1180.00
-99.00
3274.00
1766.00
-46.06%Cash Taxes Paid
$527.00
1054.00
1323.00
1016.00
885.00
735.00
780.00
234.00
229.00
341.00
467.00
535.00
0.14%Effect of Exchange Rate
$6.00
-13.00
-88.00
-332.00
-275.00
-153.00
-244.00
-88.00
7.00
-136.00
-278.00
-143.00
-2.00
-31.00
-1450.00%Increase/Decrease in Cash
$-677.00
698.00
4562.00
-2031.00
-1610.00
-695.00
-2842.00
-2851.00
1700.00
963.00
-1218.00
-460.00
-1550.00
-1144.00
26.19%Cash (Beginning)
$4263.00
3586.00
4379.00
8941.00
6910.00
5300.00
7808.00
5024.00
2173.00
3873.00
4836.00
3618.00
3618.00
3158.00
-1.48%-12.71%Cash (Ending)
$3586.00
4284.00
8941.00
6910.00
5300.00
4605.00
4966.00
2173.00
3873.00
4836.00
3618.00
3158.00
2068.00
2014.00
-1.15%-2.61%NOPAT
$3090.29
1731.50
4246.53
2921.32
2005.59
2695.83
-4122.68
-326.39
944.16
1125.57
1296.60
905.67
712.60
485.21
-10.56%-31.91%Gross Margin %
36.90%
37.50%
39.86%
41.17%
30.81%
38.07%
40.16%
41.11%
40.21%
42.41%
43.26%
43.23%
Operating Margin %
9.28%
7.52%
8.62%
10.56%
12.12%
14.15%
-18.74%
-2.76%
5.93%
8.41%
11.05%
10.30%
18.65%
13.85%
NOPAT Margin %
8.14%
4.97%
11.88%
8.41%
7.98%
10.96%
-15.69%
-2.36%
6.64%
7.19%
7.43%
5.26%
14.59%
10.80%
Net Margin %
9.15%
8.01%
13.57%
10.44%
7.77%
10.22%
-19.14%
-6.93%
4.79%
11.24%
6.57%
4.27%
12.18%
9.33%
Tax Rate %
12.31%
33.84%
-37.92%
20.36%
34.16%
22.51%
16.27%
14.56%
-12.00%
14.54%
32.75%
48.95%
21.78%
21.99%
ROA
6.37%
3.48%
8.25%
5.86%
4.87%
6.75%
-4.08%
-0.77%
2.21%
2.66%
3.04%
2.11%
1.57%
1.11%
ROE
34.10%
17.01%
26.07%
21.84%
19.66%
26.44%
-5.88%
-1.33%
3.77%
4.39%
5.08%
3.58%
2.76%
1.94%
ROIC
12.10%
6.30%
14.57%
10.02%
8.86%
12.13%
-4.84%
-1.09%
3.36%
6.24%
4.50%
3.01%
1.93%
1.57%
Asset Turnover
0.78
0.70
0.69
0.70
0.61
0.62
0.26
0.33
0.33
0.37
0.41
0.40
0.11
0.10
Inventory Turnover
2.80
2.77
2.46
2.55
2.45
1.70
1.74
1.78
1.53
1.44
0.42
0.41
Equity Multiplier
5.35
4.89
3.16
3.73
4.04
3.92
1.44
1.73
1.70
1.65
1.67
1.70
1.76
1.74
Current Ratio
1.61
1.56
1.82
1.72
1.71
1.92
1.63
1.64
1.73
1.63
1.56
1.56
1.39
1.51
Quick Ratio
0.90
0.73
1.13
1.03
1.05
1.23
0.88
0.89
1.02
0.98
0.84
0.79
0.79
0.84
Debt/Equity Ratio
1.39
1.15
0.77
0.80
0.86
0.84
0.11
0.00
0.04
0.04
0.05
0.10
0.21
0.19
Interest Coverage Ratio
7.75
5.22
6.30
9.31
8.93
9.01
-5.36
-1.45
23.42
43.90
25.71
7.58
Working Capital/Sales
0.18
0.14
0.18
0.19
0.18
0.21
0.24
0.27
0.19
0.23
0.30
0.33
1.57
1.49
R&D/Sales
0.05
0.06
0.06
0.06
0.08
0.07
0.06
0.08
0.08
0.08
0.07
0.08
0.06
0.07
Dividend Payout Ratio %
49.61%
92.06%
39.11%
58.06%
77.08%
49.52%
0.24%
-59.44%
-41.09%
-35.27%
-32.24%
48.47%
15.02%
23.08%
Total Payout
$1099.00
3288.00
2433.00
5791.00
2099.00
2877.00
5640.00
3697.00
-569.00
1769.00
1738.00
1073.00
-2941.00
-1785.00
-0.22%39.31%Payout Ratio %
35.56%
189.89%
57.29%
198.23%
104.66%
106.72%
136.80%
1132.69%
-60.27%
157.16%
134.04%
118.48%
-412.71%
-367.88%